Premium Nahrungsergänzungsmittel | artgerecht

Endocannabinoid – Definition and Function

Endocannabinoids are naturally produced signaling molecules that regulate the endocannabinoid system and influence key body functions such as pain perception, mood, and sleep.

Regular tips about health Regular tips about health

Things worth knowing about "Endocannabinoid"

Endocannabinoids are naturally produced signaling molecules that regulate the endocannabinoid system and influence key body functions such as pain perception, mood, and sleep.

What Are Endocannabinoids?

Endocannabinoids are lipid-based signaling molecules produced naturally by the human body. They bind to cannabinoid receptors and regulate a wide range of physiological processes. The term combines endo (from Greek, meaning within) and cannabinoid, indicating internally produced compounds with cannabinoid-like activity. The two most well-known endocannabinoids are anandamide (AEA) and 2-arachidonoylglycerol (2-AG).

The Endocannabinoid System

The endocannabinoid system (ECS) is a complex signaling network in the human body consisting of three main components:

Endocannabinoids – the endogenous ligands (signaling molecules)
Cannabinoid receptors – primarily CB1 and CB2 receptors
Enzymes – responsible for synthesizing and degrading endocannabinoids (e.g., FAAH, MAGL)

CB1 receptors are predominantly found in the central nervous system, whereas CB2 receptors are mainly expressed in immune tissues and peripheral organs.

Biological Functions

Endocannabinoids act as retrograde messengers: they are produced on demand and travel backward across synapses to modulate the release of other neurotransmitters. They are involved in many essential body functions, including:

Pain perception – modulation of pain signals in the nervous system
Mood and emotional well-being – regulation of anxiety, stress, and pleasure
Sleep – supporting healthy sleep onset and maintenance
Appetite and metabolism – control of hunger and energy balance
Immune function – modulation of inflammatory responses
Memory and learning – involvement in synaptic plasticity
Motor coordination – influence on movement and motor control

Anandamide and 2-AG in Detail

Anandamide (AEA)

Anandamide takes its name from the Sanskrit word ananda, meaning bliss, and is often referred to as the bliss molecule. It preferentially binds to CB1 receptors and influences mood, pain sensitivity, and the experience of anxiety. Anandamide is rapidly broken down by the enzyme FAAH (fatty acid amide hydrolase).

2-Arachidonoylglycerol (2-AG)

2-AG is the most abundant endocannabinoid in the brain and binds to both CB1 and CB2 receptors. It plays a key role in regulating inflammation, immune responses, and neuronal excitability. Its degradation is primarily carried out by the enzyme MAGL (monoacylglycerol lipase).

Medical Relevance and Therapeutic Context

Dysregulation of the endocannabinoid system has been linked to various conditions, including chronic pain syndromes, anxiety disorders, irritable bowel syndrome, fibromyalgia, and migraine. The concept of clinical endocannabinoid deficiency (CECD) describes states in which endogenous endocannabinoid production is insufficient to maintain homeostasis.

Plant-derived cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) from the cannabis plant also interact with this system and are increasingly being used therapeutically in modern medicine for indications such as neuropathic pain, chemotherapy-induced nausea, and certain forms of epilepsy.

Lifestyle Factors Affecting the Endocannabinoid System

Several lifestyle factors can influence the activity of the endocannabinoid system:

Exercise and physical activity – aerobic exercise has been shown to elevate anandamide levels (the so-called runner's high effect)
Diet – omega-3 fatty acids serve as precursor molecules for endocannabinoids
Stress – chronic stress can burden the ECS and promote dysregulation
Sleep – adequate sleep supports healthy ECS functioning

References

Pacher P., Batkai S., Kunos G. - The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews, 58(3), 389-462, 2006. PubMed.
Russo E.B. - Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. Cannabis and Cannabinoid Research, 1(1), 154-165, 2016. PubMed.
Zou S., Kumar U. - Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. International Journal of Molecular Sciences, 19(3), 833, 2018. PubMed.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.